These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26390969)

  • 1. Prostate cancer: Targetable YAP1-AR interaction key to disease progression.
    Thoma C
    Nat Rev Urol; 2015 Nov; 12(11):596. PubMed ID: 26390969
    [No Abstract]   [Full Text] [Related]  

  • 2. Androgen receptors in early and castration resistant prostate cancer: friend or foe?
    Pelekanou V; Notas G; Stathopoulos EN; Castanas E; Kampa M
    Hormones (Athens); 2013; 12(2):224-35. PubMed ID: 23933691
    [No Abstract]   [Full Text] [Related]  

  • 3. Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers.
    Marx A; Schumann A; Höflmayer D; Bady E; Hube-Magg C; Möller K; Tsourlakis MC; Steurer S; Büscheck F; Eichenauer T; Clauditz TS; Graefen M; Simon R; Sauter G; Izbicki JR; Huland H; Heinzer H; Haese A; Schlomm T; Bernreuther C; Lebok P; Polonski A
    Sci Rep; 2020 Jun; 10(1):8916. PubMed ID: 32488048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signaling promotes androgen-independent prostate cancer cell proliferation through up-regulation of the hippo pathway effector YAP.
    Seo WI; Park S; Gwak J; Ju BG; Chung JI; Kang PM; Oh S
    Biochem Biophys Res Commun; 2017 May; 486(4):1034-1039. PubMed ID: 28366633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.
    Zhang L; Yang S; Chen X; Stauffer S; Yu F; Lele SM; Fu K; Datta K; Palermo N; Chen Y; Dong J
    Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway.
    Bainbridge A; Walker S; Smith J; Patterson K; Dutt A; Ng YM; Thomas HD; Wilson L; McCullough B; Jones D; Maan A; Banks P; McCracken SR; Gaughan L; Robson CN; Coffey K
    Nucleic Acids Res; 2020 Jun; 48(10):5366-5382. PubMed ID: 32324216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAG1L: a promising therapeutic target for androgen receptor-dependent prostate cancer.
    Lee II; Kuznik NC; Rottenberg JT; Brown M; Cato ACB
    J Mol Endocrinol; 2019 May; 62(4):R289-R299. PubMed ID: 30913537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistance.
    Locke JA; Guns ES; Lehman ML; Ettinger S; Zoubeidi A; Lubik A; Margiotti K; Fazli L; Adomat H; Wasan KM; Gleave ME; Nelson CC
    Prostate; 2010 Feb; 70(3):239-51. PubMed ID: 19790237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling.
    Lai CJ; Lin CY; Liao WY; Hour TC; Wang HD; Chuu CP
    Cells; 2019 Mar; 8(4):. PubMed ID: 30935014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors.
    Nguyen LT; Tretiakova MS; Silvis MR; Lucas J; Klezovitch O; Coleman I; Bolouri H; Kutyavin VI; Morrissey C; True LD; Nelson PS; Vasioukhin V
    Cancer Cell; 2015 Jun; 27(6):797-808. PubMed ID: 26058078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells.
    Machado-Neto JA; Lazarini M; Favaro P; Franchi GC; Nowill AE; Saad ST; Traina F
    Exp Cell Res; 2014 Jun; 324(2):137-45. PubMed ID: 24726915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1.
    Zhang H; Ramakrishnan SK; Triner D; Centofanti B; Maitra D; Győrffy B; Sebolt-Leopold JS; Dame MK; Varani J; Brenner DE; Fearon ER; Omary MB; Shah YM
    Sci Signal; 2015 Oct; 8(397):ra98. PubMed ID: 26443705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAZ and YAP are frequently activated oncoproteins in sarcomas.
    Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR
    Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells.
    Dai Y; Liu S; Zhang WQ; Yang YL; Hang P; Wang H; Cheng L; Hsu PC; Wang YC; Xu Z; Jablons DM; You L
    Oncotarget; 2017 Jan; 8(3):4096-4109. PubMed ID: 27911857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population.
    Li L; Dang Q; Xie H; Yang Z; He D; Liang L; Song W; Yeh S; Chang C
    Oncotarget; 2015 Jun; 6(16):14179-90. PubMed ID: 25895025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of androgen receptor variants in hormone-sensitive prostate cancer xenografts, castration-resistant sublines, and patient specimens according to the treatment sequence.
    Honda M; Kimura T; Kamata Y; Tashiro K; Kimura S; Koike Y; Sato S; Yorozu T; Furusato B; Takahashi H; Kiyota H; Egawa S
    Prostate; 2019 Jun; 79(9):1043-1052. PubMed ID: 30998834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer.
    Ray MR; Wafa LA; Cheng H; Snoek R; Fazli L; Gleave M; Rennie PS
    Int J Cancer; 2006 Mar; 118(5):1108-19. PubMed ID: 16161052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Efflux Transporter ABCG2 Maintains Prostate Stem Cells.
    Sabnis NG; Miller A; Titus MA; Huss WJ
    Mol Cancer Res; 2017 Feb; 15(2):128-140. PubMed ID: 27856956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
    Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
    J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells.
    Dasari VR; Mazack V; Feng W; Nash J; Carey DJ; Gogoi R
    Oncotarget; 2017 Apr; 8(17):28628-28640. PubMed ID: 28404908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.